COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
- PMID: 32541689
- PMCID: PMC7294520
- DOI: 10.1038/s41409-020-0972-8
COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
Conflict of interest statement
NSS: Advisory board and speaker bureau for ibrutinib. The other authors declare no conflict of interest.
Figures
References
-
- COVID-19 Resource Community. American Society for Transplantation and Cellular Therapy. COVID-19 Resource Community; 2020. https://www.astct.org/communities/public-home?CommunityKey=d3949d84-3440....
-
- Jennings K. FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus Test Forbes2020 [updated 2020 May 7]. Available from: https://www.forbes.com/sites/katiejennings/2020/05/07/fda-authorizes-fir....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
